It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal to ...

3M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said ...

Business: Solventum, formerly known as 3M Health Care, is a global health-care company that was spun out from 3M on April 1. It has four main segments. First, there is Medical Surgical, a provider of ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

Solventum, Minnesota’s newest Fortune 500 company, is finding its footing after starting its first full year of operations on shakier ground. The 3M spinoff commenced 2025 with a deflated stock, which ...

The Solventum spin-off will help 3M prepare for legal settlements related to defective earplugs and water supply damages. 3M is risky due to potential future additional legal battles. 3M is a slow ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 CY2025 results , but sales were flat year on year at $2.10 billion. Its non-GAAP profit of $1.50 per share was 4.7% above analysts’ ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Solventum is on investors’ radar today Solventum (SOLV) is attracting fresh ...

Trian Fund Management, which beneficially owns ~5% of Solventum Corporation (SOLV) and is the company’s largest active shareholder, released an open letter and slide deck outlining its views on ...

6 analysts have shared their evaluations of Solventum (NYSE:SOLV) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick overview of ...